TWiV 947: Clinical update with Dr. Daniel Griffin
Oct 22, 2022•34 min•Ep. 947
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In his weekly clinical update Dr. Griffin discusses the prediction of upcoming global infection burden of influenza seasons after relaxation of public health and social measures during the COVID-19 pandemic, severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters, and how successful immunomodulators for treatment of COVID-19 have opened the pathway for comparative trials.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Support MicrobeTV with a Spike t-shirt at Vaccinated.US
- Prediction of upcoming global infection burden of Influenza (The LANCET)
- Severe COVID-19 outcomes after full vaccination (The LANCET)
- Successful immunomodulators for treatment of COVID-19 (CMI)
- Remdesivir fact sheet for providers (Veklury)
- Bebtelovimab fact sheet for providers (FDA)
- PAXLOVID patient eligibility screening checklist (FDA)
- Dr. Griffin’s treatment guide (pdf)
- Contribute to Floating Doctors fundraiser at PWB
- Letters read on TWiV 947
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to [email protected]
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast